Clinical trial
Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy…
NCT00186420 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186420 |
|---|---|
| Title | Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation |
| Official title | Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation |
| Lead sponsor | Stanford University, Other |
| Collaborators | Aventis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Taxotere |
| Enrollment | 13 |
| Start date | Jul 1, 2003 |
| Primary completion | Jan 1, 2006 |
| Completion | Sep 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: